New Zealand markets closed

Laboratory Corporation of America Holdings (LH)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
218.46+1.89 (+0.87%)
At close: 04:00PM EDT
219.00 +0.54 (+0.25%)
After hours: 06:10PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close216.57
Open216.74
Bid212.91 x 800
Ask218.33 x 800
Day's range215.64 - 218.67
52-week range179.59 - 234.09
Volume557,909
Avg. volume743,178
Market cap18.372B
Beta (5Y monthly)1.00
PE ratio (TTM)50.45
EPS (TTM)4.33
Earnings date25 Apr 2024
Forward dividend & yield2.88 (1.33%)
Ex-dividend date26 Feb 2024
1y target est246.80
  • PR Newswire

    Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business

    Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today that they have entered into an agreement for Labcorp to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO Health.

  • PR Newswire

    Labcorp to Announce First Quarter Financial Results on April 25, 2024

    Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the first quarter of 2024 before the market opens on Thursday, April 25, 2024. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.

  • Zacks

    Labcorp (LH) Boost Diagnostics Suite With New Biomarker Test

    Labcorp's (LH) pTau217 test is a pivotal blood biomarker intended to aid in the diagnosis of Alzheimer's disease.